Analysis of patient-completed surveys identified a higher proportion of PD patients reporting NSAID use (58%), compared with healthy controls (14%) (Table 1, univariate P-value < 0.001), and an association between plasma NLRP3 and use of certain NSAIDs and pain relievers (Table 2). Here, NLRP3 is linked to Parkinson disease.